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ABSTRACT
Background." Although congenital syphilis usually occurs as a result of a failure to detect and treat
syphilis in pregnant women, failures of the currently recommended regimen to prevent congenital
syphilis have been reported.
Case: This report describes an infant with congenital syphilis despite maternal treatment with a
regimen exceeding current CDC guidelines.
Conclusion: Regardless of the regimen used to treat syphilis during pregnancy, clinicians should
recognize the possibility of occasional treatment failures and the importance of adequate follow-up
of infants at risk for congenital syphilis. Infect. Dis. Obstet. Gynecol. 6:134-137, 1998.
(C) 1998 Wiley-Liss, Inc.
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uccessful therapy of syphilis during pregnancy
entails maternal cure as well as prevention or
cure of congenital infection. Most cases of congen-
ital syphilis occur as a result of failure to detect and
treat syphilis in pregnant women, but failures of
the recommended treatment regimen to prevent
congenital syphilis have been reported. 1-3 Al-
though some of these case reports probably repre-
sent congenital syphilis occurring as a result of un-
detected maternal reinfection after treatment, cli-
nicians should recognize that penicillin regimens
used to treat syphilis are not 100% curative.4 We
describe a case of congenital syphilis that occurred
despite maternal treatment with a penicillin regi-
men exceeding current Centers for Disease Con-
trol and Prevention (CDC) treatment guidelines,
highlighting the importance of adequate follow-up
after birth for infants at risk for congenital syphilis.
CASE REPORT
A 3S-year-old G2 P1 woman first attended a pre-
natal care clinic at 12 weeks gestational age. Rou-
tine syphilis screening was performed at this visit,
and the RPR titer was 1:256 with a positive confir-
matory MHA-TP. HIV test results were negative.
She had no symptoms or signs of neurosyphilis.
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The patient recalled that 2 months earlier she had
developed a rash on her trunk and on her extremi-
ties which extended onto her palms. Two of her 3
sex partners during the previous year were located
and evaluated for syphilis; both had negative RPR
titers.
The patient stated she was sexually active with
one partner throughout her pregnancy; he had also
been evaluated during the original contact investi-
gation and remained RPR-negative when retested.
She was treated with benzathine penicillin G, 2.4
million units intramuscularly once weekly at 14, 15,
and 16 weeks of gestation. The mother received no
additional antibiotics during pregnancy. RPR titers
(performed in the same laboratory) at 20, 28, and 36
weeks of gestation declined to 1:128, 1:64, and 1:
32, respectively. At 41 weeks of gestation, an
asymptomatic, female infant weighing 6.5 pounds
was delivered without complications. At delivery,
the mother’s RPR titer remained at 1:32. The RPR
titer on a heel-stick drawn from the infant at birth
was weakly positive, and was reported by the labo-
ratory on the day of discharge from the hospital.
Information regarding the mother’s history of
syphilis during pregnancy was not available during
a routine clinic appointment 6 weeks after birth,
and the infant’s RPR titer was not rechecked. At
age 10 weeks, the infant developed a fever, rhinor-
rhea, and a diffuse copper-colored maculopapular
rash. Congenital syphilis was not considered as a
possibility, and the infant was diagnosed with a
"viral syndrome." Two days later, a CBC was ob-
tained during re-evaluation of the infant at another
physician’s office; the white blood cell count was
72,000 mm", hematocrit 22.3%, and platelet count
36,600/mm3. The infant was admitted to the hos-
pital for further evaluation. On presentation, the
infant had a fever of 101 Farenheit, hepatomegaly,
and a normal ophthalmologic exam. There was no
evidence of sexual or other child abuse. Results of
additional laboratory studies included an RPR titer
of >1:256, negative ELISA for HIV, and normal
CSF profile with negative CSF VDRL. Radio-
graphs of the extremities demonstrated metaphy-
sitis and periosteal new bone formation, with a
bony sequestrum in the right humerus. The infant
was treated for congenital syphilis with 14 days of
intravenous penicillin (250,000 units intravenously
every 8 hours), and she recovered without further
complications. At a follow-up visit to the STD
clinic 8 weeks after the infant’s hospitalization, the
mother’s RPR titer was 1:16, and HIV serology was
again negative. At a subsequent follow-up visit to
the STD clinic 6 months later, the mother’s RPR
titer had declined to 1:4.
DISCUSSION
Based on the history of rash 2 months prior to se-
rodiagnosis, the infant’s mother had early latent
syphilis at the time she began treatment at the
beginning of the second trimester of pregnancy.
Clinical and laboratory parameters did not suggest
reinfection with Treponema pallidum later in preg-
nancy, which might have resulted in the apparent
fetal treatment failure. The decline in the mother’s
titers after delivery cannot be attributed to addi-
tional antibiotic treatment beyond that received in
the prenatal clinic, as no other antibiotics were ad-
ministered during pregnancy or the post-partum
period. Also, the mother did not have HIV infec-
tion, which published case reports suggest might
be associated with higher rates of syphilis treat-
ment failure in non-pregnant patients,s Despite
treatment of the mother with three weekly doses of
2.4 million units of penicillin, the infant was born
with congenital syphilis that was not diagnosed un-
til 10 weeks after birth. Most syphilitic infants lack
clinical manifestations at birth but nearly all cases
are clinically manifest by 12 weeks.6 Factors con-
tributing to the delayed diagnosis include unavail-
ability of the infant’s RPR results at birth to pedia-
tricians providing subsequent outpatient care for
the patient, and failure of several physicians to con-
sider the diagnosis of congenital syphilis despite a
"classic" presentation.
Current CDC treatment guidelines for treat-
ment of syphilis in pregnancy specify using a regi-
men "appropriate for the stage of syphilis". 7 The
usual treatment for early latent syphilis in adults is
intramuscular benzathine penicillin G, 2.4 milli-
units in a single dose. Recently, several investiga-
tors have questioned whether current treatment
regimens for syphilis in pregnancy are adequate for
preventing and curing fetal infection, e’8 Acknowl-
edging current evidence is not sufficient to ascer-
tain if the single dose regimen is optimal for pre-
venting and treating fetal infections, the CDC’s
1998 STD Treatment Guidelines note that some
experts recommend additional therapy (e.g., a sec-
ond dose of 2.4 million units of penicillin) week
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after the initial dose, particularly for women in the
third trimester of pregnancy and for women who
have secondary syphilis during pregnancy.7
The effectiveness of any treatment regimen is
likely to be dependent on a number of variables,
such as stage of maternal syphilis, the severity of
fetal infection, timing of treatment, and fetal tissue
penicillin levels.4 Theoretically, severe fetal infec-
tion is most likely to occur with delayed treatment
and during secondary maternal syphilis, when ma-
ternal spirochetemia is highest. More severe fetal
infections are likely to cause more impairment of
placental function, which might result in a reduc-
tion in fetal penicillin levels. The stage of preg-
nancy might also affect the likelihood of cure (e.g.,
fetal penicillin levels may be lower during the last
trimester of pregnancy when maternal pharmaco-
kinetics are altered by increased renal blood flow
and penicillin’s larger volume of distribution).4
Because penicillin therapy for maternal syphilis
cannot be assumed to prevent or cure all cases of
congenital syphilis, infants whose mothers were
treated for syphilis during pregnancy should be
evaluated clinically and serologically for evidence
of congenital syphilis. In addition, pathologic exam
of the placenta or umbilical cord is suggested if the
infant’s mother has reactive syphilis serology. De-
termining whether an asymptomatic infant has con-
genital syphilis at birth is often difficult, since (a) a
serologic response may not be present at birth in
some infants infected late in pregnancy because of
insufficient time for an antibody response to de-
velop, and (b) for infants with a positive syphilis
serology, routine laboratory studies cannot distin-
guish the passively transferred maternal antibody
from the fetal antibody. Although a neonatal titer
that is -> 4 times the maternal titer is highly sug-
gestive of congenital syphilis, infected neonates
may have titers lower than maternal titers.9
Given the limitations of conventional tests, im-
proved methods for diagnosing congenital syphilis
are desirable. Several ELISA-based tests have
been developed that are designed to detect infant
IgM antibody to Treponemapallidurn but are not yet
available for routine clinical laboratory use.9 PCR-
based techniques for diagnosing congenital syphi-
lis, first described in 1991, have excellent specific-
ity but limited sensitivity for detection of positive
specimens.1 No PCR-based test for the diagnosis
of syphilis is commercially available at present.
A seroreactive infant, or an infant whose mother
was seroreactive at delivery, who is not treated for
congenital syphilis during the perinatal period,
must receive careful follow-up examinations at 1, 2,
3, 6, and 12 months. Nontreponemal antibody ti-
ters should decline by 3 months of age and should
be nonreactive by 6 months of age if the infant was
not infected and the positive titers were the result
of a passive transfer of antibody from the mother. If
follow-up titers are stable or increasing, the infant
should be re-evaluated, including a lumbar punc-
ture, and fully treated. If treponemal antibody ti-
ters are positive at 12 months, full evaluation and
treatment of the infant are recommended. Even if
previous tests have been negative, a repeat sero-
logic test should be performed in infants who de-
velop symptoms, signs, or laboratory abnormalities
consistent with congenital syphilis.7
Although well-documented fetal treatment fail-
ures are rare, data derived from clinical trials sup-
porting current recommendations for treatment of
syphilis in pregnancy are limited. It is unlikely that
investigators will conduct trials large enough to de-
tect a difference in the efficacy of current and al-
ternative regimens for treatment of syphilis in
pregnant women. Instead, assessment of the need
for recommendations for alternative treatment is
likely to be based primarily on evidence from large
case-series documenting results with currently rec-
ommended therapy and studies of the pharmaco-
kinetics of benzathine penicillin G at different
stages of pregnancy. Regardless of the regimen
used to treat syphilis during pregnancy, clinicians
should recognize the possibility of occasional treat-
ment failures. Timely detection of these cases re-
quires careful evaluation and follow-up of infants
whose mothers were treated for syphilis during
pregnancy.
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